Register entry · No. 08335008
ISOMERASE THERAPEUTICS LIMITED
Checks
No warning signs 10 clear · 4 can't tell yet
What was checked
-
Can't tell
Insolvency
The filing history can't be read just now.
Filing history -
Can't tell
Strike-off notices
The filing history can't be read just now.
Filing history (The Gazette notices) · What this means -
Can't tell
Year-end changes
The filing history can't be read just now.
Filing history (form AA01) -
Can't tell
Office moves
The filing history can't be read just now.
Filing history (form AD01) -
Clear
Company status
Active.
Companies House register -
Clear
Accounts on time
Next due 30 Sep 2027.
Companies House register -
Clear
Confirmation statement on time
Next due 14 Nov 2027.
Companies House register -
Clear
Disqualified directors
None of the 4 current officers checked are disqualified.
Companies House disqualified directors register · See it -
Clear
Directors
4 current directors.
Officers on the register · See it -
Clear
Owners
No individual or entity with signficant control
People with significant control · See it -
Clear
Last filed accounts
Net assets £2,716,490.
Accounts to 31 Dec 2025 · See it -
Clear
Charges
None registered.
Companies House register -
Clear
Trading history
Incorporated 18 Dec 2012 (13 years ago).
Companies House register -
Clear
Name changes
Never renamed.
Names over time
From the public register, filing history, officers, owners and filed accounts, as of 20 Nov 2026. Not a credit score or advice: open the filings before relying on them. JSON
-
Registered office
Change the addressFirst Floor Newnham Building, Chesterford Research Park, Little Chesterford, Cambridge, United Kingdom, CB10 1XL
As filed with Companies House. -
Nature of business
- 72110 Research and experimental development on biotechnology
-
Accounts
- Next due
- 30 Sep 2027
- Last made up to
- 31 Dec 2025
- Type
- SMALL
-
Confirmation statement
- Next due
- 14 Nov 2027
- Last made up to
- 31 Oct 2026
-
Charges
- Outstanding
- 0
- All time
- 0
-
Names
- ISOMERASE THERAPEUTICS LIMITED current
Figures
| Year end | Turnover | Profit | Cash | Net assets | Staff |
|---|---|---|---|---|---|
| 31 Dec 2025 | not published | not published | £1,832,796 | £2,716,490 | 38 |
| 31 Dec 2024 | not published | not published | £1,393,735 | £2,914,886 | 37 |
| 31 Dec 2023 * | not published | not published | £1,743,328 | £2,828,267 | 37 |
* From the following year's accounts (prior-year figures).
Public contracts
No contracts found on Find a Tender under this company number.
Matching is by Companies House number only, so contracts filed without the number are not shown.
Contains public sector information licensed under the Open Government Licence v3.0. Source: Find a Tender award notices. JSON
Tenders this company could bid for
6 open
-
British Council
-
Agriculture and Horticulture Development Board
-
The Department for Science, Innovation & Technology (DSIT)
-
Intellectual Property Office
-
Department of Agriculture, Environment and Rural Affairs
ID 6581767 - DAERA - VSAGH - Protein of Animal Origin Testing in Feed
Matched on the company's registered business type and the tender's procurement codes. It is a starting point: check each tender's requirements before bidding.
Kestrel, our sister site, explains UK public tenders in plain English and helps you apply. Find tenders for your firm
People
Officers All 5, with past →
| Name | Role | Appointed | Resigned | Born | Nationality · lives in |
|---|---|---|---|---|---|
| Barrie Wilkinson Non-Executive Director | Director | 18 Dec 2012 | — | July 1969 | British · United Kingdom |
| Steven James Moss Cto | Director | 18 Dec 2012 | — | April 1974 | British · United Kingdom |
| Matthew Alan Gregory Ceo & Cso | Director | 18 Dec 2012 | — | July 1975 | British · England |
| Robert Alec Booth Non-Executive Director | Director | 21 Mar 2013 | — | June 1952 | British · England |
Owners and controllers All 4, with past →
No individual or entity with signficant control
From the public register. We show month and year of birth only, and no addresses. Privacy and your data
Ask about this company
Questions
Is ISOMERASE THERAPEUTICS LIMITED still trading?
The register shows ISOMERASE THERAPEUTICS LIMITED as active.
What does ISOMERASE THERAPEUTICS LIMITED do?
It files the industry code 72110 (Research and experimental development on biotechnology).
When was ISOMERASE THERAPEUTICS LIMITED set up?
It was incorporated on 18 December 2012.
When are ISOMERASE THERAPEUTICS LIMITED's accounts due?
Next accounts are due by 30 September 2027. The last accounts were made up to 31 December 2025.
When is ISOMERASE THERAPEUTICS LIMITED's next confirmation statement due?
By 14 November 2027.
Who runs ISOMERASE THERAPEUTICS LIMITED?
ISOMERASE THERAPEUTICS LIMITED has 4 current directors. They're listed under People on this page.
Similar companies
Same industry code (72110), active, set up around the same time. More in this industry →
- 08341085 CAMBRIDGE NATURAL SOLUTIONS LIMITED Active 72110 · Research and experimental development on biotechnology
- 08341001 ZIHIPP LTD Active 72110 · Research and experimental development on biotechnology
- 08340031 AXOL BIOSCIENCE LTD Active 72110 · Research and experimental development on biotechnology
- SC439312 EP PHARMACEUTICALS LTD Active 72110 · Research and experimental development on biotechnology
- 08337863 AB BIOTECHNOLOGY LIMITED Active 21100 · Manufacture of basic pharmaceutical products
The file
50 of 50 free downloads left today · Last 5 years' accounts as one zip
Filing history is loading from Companies House. Refresh in a moment.
Source: Companies House and its live updates. View on Companies House